Cosmetic Outcomes With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section
NCT ID: NCT04302597
Last Updated: 2021-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2020-05-15
2021-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Despite the available studies are often based on robust methodologies and appropriate assessment scales, most of them were aimed to evaluate cosmetic outcomes in primary cesarean section, whereas data analyses published so far do not allow to draw a firm conclusion about repeated cesarean sections. Based on these elements, the aim of this study is to evaluate cosmetic outcomes after skin closure of Pfannenstiel incision with tissue adhesive or staples in a selected population undergoing repeated cesarean section.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section
NCT06760026
Comparative Analysis of Subcuticular Suture Materials in Cesarean Section
NCT06543329
Postoperative Pain and Skin Closure Methods After Cesarean Section
NCT02028000
Subcuticular Suture Versus Staples for Closure of the Skin After Caesarean Section.
NCT01217567
Skin Closures at Cesarean Delivery, Glue vs Subcuticular Sutures.
NCT04371549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staples
Women who underwent repeated cesarean section with skin closure using staples.
Staples
Skin closure using surgical stapler.
Tissue adhesive
Women who underwent repeated cesarean section with skin closure using 2-octylcyanoacrylate tissue adhesive.
Tissue adhesive
Skin closure using 2-octylcyanoacrylate tissue adhesive.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Staples
Skin closure using surgical stapler.
Tissue adhesive
Skin closure using 2-octylcyanoacrylate tissue adhesive.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maternal age 18-45 years
* Singleton pregnancy at 37-41 weeks of gestation (based on first-trimester ultrasound) with a viable fetus
Exclusion Criteria
* Previous transversal suprapubic scars
* Clinical signs of infection and/or tattoos in the area to be studied
* Known patient hypersensitivity to any of the suture materials used in the protocol
* BMI below 20 or above 30
* Any medical disorder that could affect wound healing, including severe malnutrition, conditions requiring chronic corticosteroid use or immune suppressant, uncontrolled diabetes mellitus (defined as Hemoglobin A1c \> 6%, unbalanced daily glucose measurements, and fasting glucose \>95 mg/dL).
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi dell'Insubria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Simone Laganà
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonella Cromi, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi dell'Insubria
Fabio Ghezzi, M.D.
Role: STUDY_CHAIR
Università degli Studi dell'Insubria
Antonio Simone Laganà, M.D., Ph.D.
Role: STUDY_CHAIR
Università degli Studi dell'Insubria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale "Filippo Del Ponte"
Varese, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GLUE-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.